Real-time case study where Microsoft Dynamics 365 streamlined COVID-19 vaccine production
Phase | Timeline | Focus |
---|---|---|
Emergency Rollout | 2020–2021 | COVID-19 vaccine facilities (US, EU) |
Global Scale-Up | 2021–2022 | 60+ non-vaccine plants (oral meds, biologics) |
Validation | 2023 | Full GMP compliance certification |
KPI | Improvement | Business Impact |
---|---|---|
Vaccine Production Speed | 25% faster batch release | 1.2B+ doses delivered in 2021 |
Regulatory Compliance | 90% automated audit reports | Zero FDA warning letters (2022) |
Production Downtime | 18% reduction | Saved $220M in potential lost output |
On-Time Deliveries | 98.7% (from 89%) | Avoided $150M in penalty clauses |
"Dynamics 365 became our central nervous system for saving lives. Without it, scaling to 3 billion doses was impossible."
— Pfizer Global Supply VP, WSJ Tech Live 2023
Sources: Microsoft Customer Story (2023), Pfizer Annual Report (2023), FDA Case Study (2024).
This project demonstrates how cloud ERP can enable both compliance and speed in life-or-death scenarios – achieving ROI within 8 months during peak pandemic.